Houston researchers say a beefed-up flu shot might do more than keep seniors out of bed with the sniffles. A large new analysis finds that older adults who received the high-dose influenza vaccine had a lower short-term rate of Alzheimer’s disease than peers who got the standard shot. The effect was most noticeable in the first two years after vaccination and appeared stronger in women. Both the study team and outside experts stress this is an association, not proof that a single jab prevents Alzheimer’s.
In findings published in Neurology, investigators used U.S. health-claims data from 2014 to 2019 to emulate a series of target trials comparing Fluzone High-Dose with standard-dose inactivated influenza vaccines among adults 65 and older. The high-dose group included about 120,775 unique participants, accounting for 185,183 person-trials, while the standard-dose group included 44,022 participants and 53,918 person-trials. Over the first 25 months after vaccination, the authors reported a statistically significant reduction in new Alzheimer dementia diagnoses in the high-dose group. The maximum absolute risk difference was modest, roughly 0.54 percentage points, with a number needed to treat of about 185, which means the benefit is measurable at the population level but small for any given individual.
The research was led by a UTHealth Houston team, which launched the project after local public-health officials asked whether vaccine dose strength might matter. In a press release summarized by MedicalXpress, senior author Paul Schulz said, "I was stunned that, as a physician, I didn't know a higher dose was offered." The group noted that their earlier analyses had linked routine flu vaccination with roughly a 40% lower Alzheimer risk compared with no flu vaccination at all.
What the high-dose flu shot actually is
The Centers for Disease Control and Prevention already recommends that people 65 and older receive a higher-dose or adjuvanted flu vaccine, since older immune systems tend to react less strongly to standard shots. The high-dose product contains about four times the antigen found in standard inactivated vaccines, which is intended to boost antibody responses, according to the CDC. Because that guidance is already in place, the new study supports current vaccine advice for seniors rather than overturning it.
Experts pump the brakes on bold claims
Outside experts told reporters that if the finding holds up, the most plausible explanation is indirect. Better protection against flu could mean fewer episodes of widespread inflammation in the body, which in turn might contribute less to the kind of neurodegeneration seen in Alzheimer’s disease. Dr. Marc Siegel, speaking to Fox News Digital, said the interaction "could decrease inflammation and thereby indirectly decrease Alzheimer's risk." The Neurology authors themselves note that the work relies on claims-based diagnoses, has limited follow-up and sociodemographic information, and cannot rule out residual confounding, so randomized trials or studies anchored in biological markers would be needed to test whether the vaccine dose truly causes the difference in risk.
What this means for older adults right now
The study adds to a growing line of research hinting that vaccines may have broader health effects beyond stopping specific infections, but it does not prove the high-dose flu shot prevents Alzheimer’s disease. Public-health authorities continue to recommend that adults 65 and older follow existing CDC guidance on which flu products are appropriate and discuss options with their clinicians, especially given the modest absolute benefit reported here. For the latest details on vaccine choices for seniors, the CDC remains the go-to source.
